RILOGROTUG
UNII LI86LS4ZUR

Substance Identification & Data

This profile provides standardized clinical and technical data for Rilogrotug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LI86LS4ZUR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2894138-72-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
LI86LS4ZUR
CAS Registry Number
2894138-72-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RILOGROTUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C200801
National Cancer Institute reference terminology for clinical and research data.
INN ID
13236
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
LM-218
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rilogrotug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RILOGROTUG

Common Names & Synonyms

AV-380 (GDF15 MAB)
IMMUNOGLOBULIN G1, ANTI-(HUMAN GROWTH DIFFERENTIATION FACTOR 15) (HUMAN-MUS MUSCULUS MONOCLONAL AV-380 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AV-380 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS GROWTH/DIFFERENTIATION FACTOR 15 (GDF15), MACROPHAGE INHIBITORY CYTOKINE 1 (MIC-1)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV1-69*02 (83.7%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.13) (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*03 (100%), G1M3, NG1M1 CH1 R120, CH3 E12, M14 (CH1 R120 (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)), (223-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V- KAPPA (HOMO SAPIENS IGKV1-27*01 (83.2%) -IGKJ2*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
RILOGROTUG [USAN]

Technical Codes

AV-380

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus